Bioreactors Market Report 2026

Bioreactors Market Overview

• Bioreactors market size has reached to $10.61 billion in 2025 • Expected to grow to $21.03 billion in 2030 at a compound annual growth rate (CAGR) of 14.6% • Growth Driver: Rising Demand For Biopharmaceuticals Driving Growth In The Market • Market Trend: Advancements In Bioreactor Technology Enable Seamless Scalability For Efficient Biomanufacturing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bioreactors Market?

A bioreactor is a controlled system designed to support biological processes by providing a suitable environment for cells, microorganisms, or enzymes to grow and function. It maintains optimal conditions such as temperature, pH, oxygen, and nutrient supply to facilitate desired biochemical reactions. Bioreactors are widely used in pharmaceuticals, food production, and wastewater treatment. The main types of bioprocesses for bioreactors are batch, fed-batch, and continuous. Bioreactors support both batch and fed-batch processes, providing flexibility to optimize production based on product complexity and desired yields. It applies to various cells, such as mammalian cells, bacterial cells, yeast cells, and others, with several control types, including manual and automated. It is used for various usages, such as lab-scale production, pilot-scale production, and full-scale production, and is used by several end users, including research and development (R&D) organizations, biopharmaceutical (biopharma) manufacturers, and contract manufacturing organizations (CMOs).

What Is The Bioreactors Market Growth Forecast?

The bioreactors market size is expected to see rapid growth in the next few years. It will grow to $21.03 billion in 2030 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing demand for high-yield bioprocessing, expansion of personalized medicine manufacturing, rising integration of ai-driven process optimization, growing focus on production efficiency, increasing adoption of continuous manufacturing models. Major trends in the forecast period include increasing adoption of automated bioreactor systems, rising use of continuous bioprocessing technologies, growing demand for scalable bioreactor platforms, expansion of single-use bioreactor solutions, enhanced focus on process monitoring and control.

What Is The Driver Of The Bioreactors Market?

The increasing demand for biopharmaceuticals is expected to propel the growth of the bioreactors market going forward. Biopharmaceuticals are medicinal products derived from biological sources, such as proteins, cells, and living organisms, used to prevent, treat, or manage various diseases. The increasing demand for biopharmaceuticals is due to advancements in medical research, personalized medicine, and the need for innovative treatments, leading to improved healthcare outcomes worldwide. Bioreactors are useful for biopharmaceuticals as they enable efficient and scalable production of therapeutic products, ensuring consistent quality, reducing production costs, and facilitating the development of innovative and life-enhancing medicines. For instance, in November 2025, according to the Organisation for Economic Co operation and Development, a France-based intergovernmental economic organization, reported that per capita expenditure on retail pharmaceuticals averaged USD 766 (adjusted for differences in purchasing power) in OECD countries in 2023. Therefore, increasing demand for biopharmaceuticals is driving growth in the bioreactors industry.

Key Players In The Global Bioreactors Market

Major companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, PBS Biotech Inc., TAP Biosystems, BBI-Biotech GmbH, HiTec Zang GmbH, Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, Shanghai Ritai Medicine Equipment Project Co. Ltd.

Global Bioreactors Market Trends and Insights

Major companies operating in the bioreactors market are focusing on developing advanced products such as fixed-bed bioreactors to support the growth of more complex biological cultures. A fixed-bed bioreactor is a type of bioreactor in which biological organisms are attached to a solid support, typically composed of porous materials such as beads, fibers, or granules. This design enhances mass transfer, minimizes shear stress, and provides better control over the biological processes. For instance, in October 2024, Univercells Technologies, a Belgium-based biotechnology company, launched the Scale-X Nexo bioreactor. This cutting-edge bioreactor, featuring a 0.5 m² growth surface, is specifically designed to optimize cell culture process development, offering significant benefits for biopharmaceutical companies and research institutions. The scale-X nexo facilitates seamless scalability to larger models, reduces media and reagent consumption, and can lower operational costs by up to 60% compared to traditional entry-level bioreactors. Additionally, it integrates with the Skaia Vision application software, further boosting productivity by providing precise cell count estimations without the need for direct sampling.

What Are Latest Mergers And Acquisitions In The Bioreactors Market?

In March 2025, Syngene International (a Biocon subsidiary), an India-based contract research and manufacturing organization (CRDMO), acquired a U.S. biologics facility from Operations Baltimore, LLC, which is a unit of Emergent BioSolutions, Inc. With this acquisition, Syngene aims to expand its bioprocessing capacity, specifically its single-use bioreactor infrastructure, to serve more biologics and volume-intensive clients. Emergent BioSolutions is a U.S.-based biopharmaceutical company that previously operated the acquired manufacturing facility with bioreactors for large-scale biologics production.

What Defines the Bioreactors Market?

The bioreactors market consists of sales of stirred-tank bioreactors (STRs), airlift bioreactors, bubble column bioreactors, and packed-bed bioreactors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioreactors Market Report 2026?

The bioreactors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioreactors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.